Comment regarding benefit in phase 1 oncology trials.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Morse, M

Published Date

  • 2008

Published In

Volume / Issue

  • 5 / 6

Start / End Page

  • 626 -

PubMed ID

  • 19029212

Pubmed Central ID

  • 19029212

International Standard Serial Number (ISSN)

  • 1740-7745

Digital Object Identifier (DOI)

  • 10.1177/1740774508098682

Language

  • eng

Conference Location

  • England